{
  "id": 20798517,
  "title": "Commonly mutated gene could be a therapeutic target in sarcoma",
  "url": "https://urgent.news/2026/11/19/commonly-mutated-gene-could-be-a-therapeutic-target-in-sarcoma",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-19T19:40:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-commonly-mutated-gene-therapeutic-sarcoma.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Researchers at The University of Texas MD Anderson Cancer Center have discovered that sarcomas lacking the ATRX gene tend to be more aggressive and may be particularly vulnerable to a class of targeted therapies known as TEAD inhibitors. The findings identify ATRX loss as both a marker of poor prognosis and a potential therapeutic target.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}